Convergence Investment Partners, LLC Bristol Myers Squibb CO Transaction History
Convergence Investment Partners, LLC
- $431 Million
- Q4 2024
A detailed history of Convergence Investment Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 90,493 shares of BMY stock, worth $5.05 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
90,493
Previous 83,605
8.24%
Holding current value
$5.05 Million
Previous $4.33 Million
18.31%
% of portfolio
1.19%
Previous 1.18%
Shares
27 transactions
Others Institutions Holding BMY
# of Institutions
2,751Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.36 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.31 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...